netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 9: Nutrition and blood - Full Chapter
09.01  Anaemias and some other blood disorders
09.01.01  Iron-deficiency anaemias
09.01.01.01  Oral iron
Ferrous fumarate
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated (not Galfer)
  • RFL:
    • Non-formulary
  • RNOH:
    • Oral syrup available as 140 mg/5mL
  • UCLH:
  • WH:
    • Oral syrup available as 140 mg/5mL (ONLY formulation available)
 
Ferrous gluconate
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Ferrous gluconate contains a lower content of elemental iron and therefore may be better tolerated than ferrous sulphate.
 
Ferrous sulphate
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • First choice for iron-deficiency anaemia
  • UCLH:
  • WH:
    • No restriction stated
 
Ferrous sulphate modified release
(Ferrograd®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Sodium Feredetate
(Sytron®)
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Neonatal/paediatrics only
 
09.01.01.01  Iron and folic acid
Ferrous fumarate + Folic acid
(Pregaday®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.01.01.01  Compound iron preparations to top
09.01.01.02  Parenteral iron
Ferric Carboxymaltose
(Ferinject®)
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
AAAAAAAA

See local guidance for iron replacement

Approved for:


  1. Iron deficient anaemia in Obstetrics (January 2017)
  2. Iron deficient anaemia in adult outpatients only, not in patients in first trimester of pregnancy or for patient on haemodialysis (March 2017)

Provider notes

  • NMUH:
    • To be used for day case patients and out patients ONLY
    • See link below for parenteral irons prescribing guideline.
    • Ferinject must be prescribed on the specific Daycase Ferinject prescription form; see link below
    • Note: Parenteral iron is contraindicated in the first trimester of pregnancy. For dose of Ferinject in patients with haemodialysis dependent chronic kidney disease, refer to the summary of prouct characteristics.
    • Check MHRA Drug Safety updates
  • RFL:
    • Approved for use in private patients at RFL
    • Approved for use in renal and liver patients at RFH
  • RNOH:
    • For the optimisation of pre-operative anaemia in patients aged 14 to 17 years.
  • UCLH:
    • Restricted to outpatients / daycase / facilitate inpatient discharge
  • WH:
    • Parenteral iron should only be considered if oral therapy has failed due to lack of patient co-operation, severe gastrointestinal side effects, continuing severe blood loss or malabsorption. Provided oral therapy is taken reliably and is absorbed, then the haemoglobin response is not significantly faster with the parenteral route.
 
Link  NMUH: The Daycase Ferinject Prescription Form
Link  NMUH: The Trust guidelines on use of parenteral irons for iron deficiency anaemia
Ferric derisomaltose (previously iron isomaltoside)
(Monofer®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

See local guidance for iron replacement

Provider notes

  • NMUH:
    • Check MHRA Drug Safety update
  • RFL:
    • First-choice of fast infusion product (excluding renal)
    • Available to all patient groups at BH and CFH.
    • Restricted to specific patient groups at RFH:
      • For patients who would otherwise require multiple iron infusions, and there is a documented reason why multiple infusions would impact on patient’s quality of life
      • For patients on 2NA in whom a shorter duration iron infusion is indicated, and there is documented reason why a longer infusion would impact on patient’s quality of life
      • For patients in whom there is an URGENT need for IV iron e.g. patients planned for Theatre, or for pregnancy
      • For patients on a cancer pathway to enable cancer treatment to proceed
      • For patients with disabling anaemia who require urgent correction of Hb levels, based on clinical symptoms/clinical need (patient-specific need)
      • For patients who have experienced serious / life-threatening allergies or adverse events to other IV iron products
  • RNOH:
    • For the optimisation of pre-operative anaemia in accordance with local guideline. Oral iron must be used where surgery is not urgent
  • UCLH:
  • WH:
    • Non-formulary
 
Iron Dextran (CosmoFer®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

See local guidance for iron replacement

Provider notes

  • NMUH:
    • See link below to access the Trust guidelines on use of parenteral irons for iron deficiency anaemia
    • Check MHRA Drug Safety updates
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary 
 
Link  NMUH: The Trust guidelines on use of parenteral irons for iron deficiency anaemia
Iron Sucrose (Venofer®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

See local guidance for iron replacement

Provider notes

  • NMUH:
    • See Trust guidelines on use of parenteral irons for iron deficiency anaemia; link below
    • Check MHRA Drug Safety updates
  • RFL:
    • Renal anaemia only - Venofer and Cosmofer are preferred choices
  • RNOH:
    • Preferred parenteral iron preparation for inpatients
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NMUH: The Trust guidelines on use of parenteral irons for iron deficiency anaemia
09.01.02  Drugs used in megaloblastic anaemias
Cyanocobalamin
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
Folic Acid
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
    • When used in combination with oral methotrexate various regimens are used from once-weekly, twice-weekly to daily use (except on day of methotrexate)
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Folic acid is indicated in confirmed folate deficiency due to dietary lack, gastrointestinal disease, pregnancy, chronic haemolytic states, myeloproliferative disorders, haemodialysis, and parenteral nutrition, intensive care of the very sick patient or in premature infants. Folic acid can be used to correct serious haematological changes caused by dihydrofolate reductase inhibitors (DFRIs), after the DFRI has been discontinued. Examples of DFRIs include trimethoprim and co-trimoxazole.
    • Before treating megaloblastic anaemia with folic acid alone, vitamin B12 deficiency MUST be excluded. Folic acid may relieve the haematological features of vitamin B12 deficiency and allow neuropathy to develop undetected. If treatment must be started immediately, both folic acid and hydroxocobalamin should be given.
 
Hydroxocobalamin
(Vitamin B12)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
09.01.03  Drugs used in hypoplastic, haemolytic, and renal anaemias
Eculizumab infusion
(Haemolytic uraemic syndrome)
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
High Cost Medicine
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • As per NICE
  • RNOH:
    • Non-formulary
  • UCLH:
    • See links below
  • WH:
    • Non-formulary
 
Link  NICE HST1: Eculizumab for treating atypical haemolytic uraemic syndrome
Hydroxycarbamide
(Sickle cell)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Hydroxycarbamide Suspension 50mg/5ml (100 ml) unlicensed preparation is also available
  • RFL:
    • Restricted to Haematology
    • Not prescribed on Chemocare for this indication
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.01.03  Erythropoietin
Darbepoetin alfa
(Aranesp®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • For continuation of supply for those renal patients that have been initiated on treatment by Royal Free Hospital.
  • RFL:
    • Restricted to Renal team – preferred brand of erythropoietin
    • Restricted to Haematology for MDS
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • As per NICE TA 323
 
Link  NICE TA323: Erythropoiesis‑stimulating agents during chemotherapy
Epoetin alfa (Eprex®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • For anaemia associated with chronic renal failure only.
    • Restricted to renal consultants signature and Dr. Tindall signature only.
    • Please note that the CSM has advised that the subcutaneous route is contraindicated in chronic renal failure. Please use the IV route instead. The dialysis unit has changed over to NeoRecormon which is an IV preparation.
  • RFL:
    • Restricted to Renal team - for patients who cannot tolerate darbepoetin or established patients only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Epoetin is available for treatment anaemia of renal disease only
 
Link  NICE TA323: Erythropoiesis‑stimulating agents during chemotherapy
Epoetin beta
(NeoRecormon®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Positive NICE TA This medicine has a positive NICE Technology Appraisal and is listed in the Trust Medicines Formulary when used  in line with NICE recommendations and/or Local Trust Guidelines.
    • Restricted to Renal and Haematology Consultants.
    • See MHRA drug safety updates 
  • RFL:
    • Restricted to Renal team - for patients who cannot tolerate darbepoetin or established patients only
    • Restricted to Haematology for MDS
  • RNOH:
    • Store in a refrigerator
  • UCLH:
  • WH:
    • Epoetin is available for treatment anaemia of renal disease only
    • Pre-filled syringe 2,000 units, 3,000 units, 4,000 units, 6,000 units, 10,000 units ONLY
 
Link  NICE TA323: Erythropoiesis‑stimulating agents during chemotherapy
Methoxy Polyethylene Glycol-Epoetin Beta
(Mircera®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary.
  • RFL:
    • Restricted to renal team only - for patients who cannot tolerate darbepoetin or established patients only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.01.03  Iron overload to top
Deferasirox
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • See links below
  • RFL:
    • Commissioned as per NHS England policy for haemoglobinopathies.
    • Confirm with the commissioning team regarding other indications.
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NHSE 16070/P: Treatment of iron overload for transfused and non transfused patients with chronic inherited anaemias
Link  NMUH: The formulary awareness bulletin on defersirox (Exjade)
Deferiprone
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    •  To be prescribed by the Haematology Team ONLY.
    • See links below
  • RFL:
    • Commissioned as per NHS England policy for haemoglobinopathies.
    • Confirm with the commissioning team regarding other indications.
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Tabs 500 mg ONLY
 
Link  NHSE 16070/P: Treatment of iron overload for transfused and non transfused patients with chronic inherited anaemias
Desferrioxamine Mesilate
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • To be prescribed by the Haematology Team ONLY.
    • See links below
  • RFL:
    • Commissioned as per NHS England policy for haemoglobinopathies.
    • Confirm with the commissioning team regarding other indications.
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NHSE 16070/P: Treatment of iron overload for transfused and non transfused patients with chronic inherited anaemias
09.01.04  Drugs used in autoimmune thrombocytopenic purpura
Avatrombopag tabs
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

See NICE TA for eligibility criteria

Provider notes

  • NMUH: 
    • As per NICE TA626 
  • RFL: 
    • Non-formulary 
  • RNOH: 
    • Non-formulary 
  • UCLH: 
  • WH: 
    • Non-formulary 
 
Link  NICE TA626: Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
Eltrombopag
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Positive NICE TA This medicine has a positive NICE Technology Appraisal and is listed in the Trust Medicines Formulary when used in line with NICE recommendations and/or Local Trust Guidelines see link below.
  • RFL:
    • As per NICE guidance and CCG policy
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • See links below
 
Link  NICE TA293: Eltrombopag for treating chronic ITP
Link  NICE TA382 (not recommended): Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)
Lusutrombopag tabs
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

See NICE TA for eligibility criteria

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • As per NICE TA 617
 
Link  NICE TA617: Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
Romiplostim
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Positive NICE TA This medicine has a positive NICE Technology Appraisal and is listed in the Trust Medicines Formulary when used in line with NICE recommendations and/or Local Trust Guidelines.
  • RFL:
    • As per NICE guidance and CCG policy
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH    approvals:
    • As per NICE TA 221
 
Link  NICE TA221: Thrombocytopenic purpura - romiplostim
09.01.05  G6PD deficiency
09.01.06  Drugs used in neutropenia
Filgrastim
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
AAAAAAAA

Provider notes

  • NMUH:
    • Zarzio® is the preferred brand
    • Check MHRA Drugs Safety Alerts
    • See link below
  • RFL:
    • Accofil® is the preferred brand (from June 2019)
  • RNOH:
    • Requires HAEMATOLOGIST approval
    • Store in a refrigerator
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NMUH: The Formulary Awareness Bulletin on filgrastim (Zarzio®)
Lenograstim (Granocyte®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Restricted for use in paediatric patients ONLY. For Adult patients, use filgrastim (Zarzio) first line.
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Lipegfilgrastim
(Patients who cannot inject daily)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Alternative to GCSF + district nurse administration at WH only for patients who can receive daily GCSF but cannot self-inject (JFC August 2016)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • For use by oncology consultants only in patients unable to receive daily GCSF infections or needle phobic patients (D&TC Sept 2016)
 
09.01.07  Drugs used to mobilise stem cells
09.02  Fluids and electrolytes to top
09.02.01  Oral preparations for fluid and electrolyte imbalance
09.02.01.01  Oral potassium
Potassium Chloride oral
(Kay-Cee-L®)
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • See link below
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Potassium Chloride oral
(Sando-K®)
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • See link below
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Effervescent potassium is preferred to the modified release preparation as it is associated with less risk of oesophageal ulceration. Effervescent potassium can be administered via a nasogastric tube.
 
Potassium Chloride oral
(Slow-K®)
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • See link below
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Effervescent potassium is preferred to the modified release preparation as it is associated with less risk of oesophageal ulceration. Effervescent potassium can be administered via a nasogastric tube.
 
09.02.01.01  Potassium removal
Patiromer sorbitex calcium
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
AAAAAAAA

See NICE TA for eligibility criteria

Provider notes

  • NMUH:
    • As per NICE TA623
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • As per NICE TA623
 
Link  NICE TA623: Patiromer for treating hyperkalaemia
Polystyrene Sulphonate Resins
(Calcium Resonium®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • The rectal route should be reserved for patients who are vomiting or have upper gastrointestinal tract problems, including paralytic ileus or it may be used simultaneously with the oral route for more rapid initial results.
    • See BNF for instructions on administration. Please consult product literature for further information.
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • 'Calcium Resonium' exchanges potassium ions for calcium ions. It should be avoided in patients with hypercalcaemia, as it further raises calcium levels.
    • Adult dose:
      • Oral: 15 g PO 6 to 8 hourly in water (not fruit juice which has a high K+ content)
      • Rectal: 30g once daily. Made by adding 30g of Calcium Resonium resin to 200ml Methylcellulose 1% solution. The retention enema is left in situ for 9 hours. Although rectal administration may be useful vomiting is a problem, the oral preparation may be preferred by some patients despite some nausea.
    • In initial stages, Calcium Resonium may be given both rectally and orally to achieve a more rapid lowering of serum potassium. Administration should be stopped once potassium reaches 5.0 mmol/L. Onset of action is between 2 and 12 hours.
 
Polystyrene Sulphonate Resins
(Resonium A®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • 'Resonium A' exchanges potassium ions for sodium. It should be avoided in patients with congestive heart failure, water and salt overload, hypertension or where dietary sodium content is medically restricted.
 
Sodium zirconium suspension
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
AAAAAAAA

See NICE TA for eligibility criteria

Provider notes

  • NMUH:
    • As per NICE TA599
    • See Management of hyperkalaemia guideline
  • RFL:
    • Non-formulary
  • RNOH:
    • As per NICE TA599
  • UCLH:
  • WH:
    • As per NICE TA
 
Link  NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia
09.02.01.02  Oral sodium and water
Sodium Chloride 30% oral
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Sodium Chloride oral
(Slow Sodium®)
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.02.01.02  Oral rehydration therapy (ORT) to top
Oral Rehydration Salts
(Dioralyte®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Oral Rehydration Salts
(Dioralyte® Relief)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Oral Rehydration Salts
(St. Marks’ Solution)
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • St. Marks’ Solution is not kept at NMUH but all ingredients are available individually (i.e. sodium chloride, sodium bicarbonate and anhydrous glucose).
  • RFL:
    • St. Marks’ Solution is not kept at RFL but all ingredients are available individually (i.e. sodium chloride, sodium bicarbonate and anhydrous glucose).
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Oral Rehydration Salts
(WHO Formulation)
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • WHO Oral Rehydration Powder is not kept at RFL but all ingredients are available individually (i.e. sodium chloride, potassium chloride, sodium citrate and anhydrous glucose).
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.02.01.03  Oral bicarbonate
Sodium Bicarbonate oral
(Electrolyte imbalance)
View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Oral solution - unlicensed preparation, (5mmol / 5mL) also available for correction of acidosis in paediatric patients
  • RFL:
    • 500mg capsules and 1mmol/mL oral solution stocked
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • The use of sodium bicarbonate capsules is restricted to the Renal team only. Caps 500 mg containing approximately 6 mmol of Na+ and HCO3-
 
09.02.02  Parenteral preparations for fluid and electrolyte imbalance
09.02.02.01  Electrolytes and water
09.02.02.01  Intravenous sodium
Ringer's Solution for Injection
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Only use if Hartmann’s is unavailable
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Sodium Chloride + Glucose Intravenous Infusion
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Sodium chloride 0.18% and glucose 4% (500 mL)
    • Sodium chloride 0.45% and glucose 5% (500 mL)
  • UCLH:
  • WH:
    • No restriction stated
 
Sodium Chloride intravenous solutions
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Sodium chloride 0.9% (10 mL, 100 mL, 250 mL, 500 mL and 1000 mL)
    • Sodium chloride 0.45% (500 mL)
    • Sodium chloride 2.7% (500 mL)
  • UCLH:
  • WH:
    • No restriction stated
 
09.02.02.01  Intravenous glucose to top
Glucose Intravenous
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Glucose 5% (100 mL, 250 mL, 500 mL and 1000 mL)
    • Glucose 10% (500 mL)
    • Glucose 20% (500 mL)
    • Glucose 50% (50 mL)
    • Glucose 1% in compound sodium lactate (Hartmann's) (1000 mL)
  • UCLH:
  • WH:
    • No restriction stated
 
09.02.02.01  Intravenous potassium
Potassium Chloride + Glucose Intravenous Infusion
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Administer according to IV Potassium Policy
  • RNOH:
    • Potassium chloride 0.15% and glucose 5% (1000 mL)
    • Potassium chloride 0.30% and glucose 5% (1000 mL)
  • UCLH:
  • WH:
    • No restriction stated
 
Potassium Chloride + Sodium Chloride + Glucose Intravenous Infusion
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Administer according to IV Potassium Policy
  • RNOH:
    • Potassium chloride 0.15%, sodium chloride 0.18% and glucose 4% (1000 mL)
    • Potassium chloride 0.30%, sodium chloride 0.18% and glucose 4% (1000 mL)
    • Potassium chloride 0.15%, sodium chloride 0.45% and glucose 5% (500 mL) - for use by ADU/Coxen and CHDU
    • Potassium chloride 10mmol with sodium chloride 0.9% and glucose 5% is no longer available. An equivalent fluid can be prepared by adding 50 ml of 50% glucose to 500 mL potassium chloride 0.15% and sodium chloride 0.9%
  • UCLH:
  • WH:
    • Infusion 500 ml (15 mmol Na+ and 10 mmol K+, 80 kcal)
    • Infusion 1000 ml (30 mmol Na+ and 20 mmol K+, 160 kcal
 
Potassium Chloride + Sodium Chloride Intravenous Infusion
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Administer according to IV Potassium Policy
  • RNOH:
    • Potassium chloride 0.15% and sodium chloride 0.9% (500 mL and 1000 mL)
    • Potassium chloride 0.30% and sodium chloride 0.9% (500 mL and 1000 mL)
    • Unlicensed: Potassium Chloride 3% in Sodium Chloride 0.9% Intravenous Infusion (40 mmol in 100 mL). Must be ordered and stored as a Controlled Drug. Restricted to ITU only.
  • UCLH:
  • WH:
    • No restriction stated
 
Potassium Chloride 15% Concentrate for Solution for Infusion
View adult BNF View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Restricted to NICU and Renal Dialysis Wards (for addition to dialysis fluids bags only)
    • Must be ordered and stored as a controlled drug. 
    • Administer according to IV Potassium Policy
  • RNOH:
    • Must be ordered and stored as a Controlled Drug. Restricted to ITU, Theatres and Recovery only
  • UCLH:
  • WH:
    • The ready-made potassium solutions should cover most requirements and should be used in preference to the strong injection.
 
Potassium Chloride 40mmol in 100ml Water For Injection
View adult BNF View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Restricted to ICU
    • Administer according to IV Potassium Policy
  • RFL:
    • Restricted to ICU and Cardiac Resuscitation Trolleys only
    • Administer according to IV Potassium Policy
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.02.02.01  Bicarbonate and lactate
Compound Sodium Lactate (Hartmann's) Intravenous Infusion
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • 500 mL and 1000 mL
  • UCLH:
  • WH:
    • No restriction stated
 
Sodium Bicarbonate intravenous
(Electrolyte imbalance)
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • 1.26%, 2.74%, 4.2% and 8.4% polyfusor 500mL
  • RNOH:
    • 8.4%: 10 mL, 100 mL and 200 mL Polyfusor
  • UCLH:
  • WH:
    • No restriction stated
 
Sodium Bicarbonate intravenous
(Min-I-Jet® Sodium Bicarbonate)
(Electrolyte imbalance)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.02.02.01  Water
Water for Injections
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • 10 mL
  • UCLH:
  • WH:
    • No restriction stated
 
Water for Irrigation
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Available as 500 mL and 1000 mL bottles or 1000 mL and 3000 mL bags
  • UCLH:
  • WH:
    • No restriction stated
 
09.02.02.02  Plasma and plasma substitutes
Albumin Solution
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Available via the blood bank
  • RNOH:
    • Available from Pathology
  • UCH approvals:
  • WH:
    • No restriction stated
 
09.02.02.02  Plasma substitutes to top
Gelatin intravenous infusion
(Gelaspan®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • BCF: No restriction stated
    • RFH: Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Gelatin intravenous infusion
(Gelofusine®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • BCF: Non-formulary
    • RFH: No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Gelatin intravenous infusion
(Geloplasma®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Gelatin intravenous infusion
(Volplex®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Plasma-lyte 148
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to Barnet ICU
  • RNOH:
    • Non-formulary
  • UCLH:
    • Non-formulary
  • WH:
    • Non-formulary
 
09.03  Intravenous nutrition
Parenteral Nutrition (TPN or PN)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • RFL:
    • Contact Nutrition team for advice
 
Supplementary Preparations
(Addiphos®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Supplementary Preparations
(Additrace®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Supplementary Preparations
(Cernevit®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Supplementary Preparations
(Peditrace®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Supplementary Preparations
(Solivito N®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Supplementary Preparations
(Vitlipid N®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.03  Supplementary preparations
09.04  Oral nutrition
09.04.01  Foods for special diets
09.04.02  Enteral nutrition to top
09.05  Minerals
09.05.01  Calcium and magnesium
09.05.01.01  Calcium supplements
Calcium Carbonate
(Adcal®)
(Calcium supplement)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Calcium carbonate
(Cacit®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • For patients requiring effervescent calcium carbonate
  • UCLH:
  •  WH:
    • Non-formulary
 
Calcium carbonate
(Calcichew®)
(Calcium supplement)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
Calcium Chloride injection
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Calcium Gluconate 10% injection
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Calcium Gluconate effervescent tablets
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • BCF: No restriction (historical)
    • RFH: Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
Sandocal-1000®
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
09.05.01.02  Hypercalcaemia and hypercalciuria
Cinacalcet
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Approved for complex primary hyperparathyroidism in adults in line with NHSE clinical commissioning policy (JFC April 2018)

Provider notes

  • NMUH:
    • This medicine has a positive NICE Technology Appraisal and is listed in the Trust Medicines Formulary when used in line with NICE recommendations and/or Local Trust Guidelines.
    • For continuation of supply for those renal patients that have been initiated on treatment by Royal Free Hospital.
    • Formulary for treatment of Hypercalcaemia of primary hyperparathyroidism or parathyroid carcinoma - see link below
  • RFL:
    • Restricted to ‘cinacalcet gatekeeper’ approval only for secondary hyperparathyroidism – see NICE TA.
    • Restricted to endocrinology for complex primary hyperparathyroidism – see NHSE commissioning policy
  • RNOH:
    • Non-formulary
  • WH:
    • For primary hyperparathyroidism in line with NHSE policy 16034/P
    • For secondary hyperparathyroidism in line with NICE TA 117
 
Link  NHSE 16034/P: Cinacalcet for complex primary hyperparathyroidism in adults
Link  NICE TA117: Hyperparathyroidism - cinacalcet
Etelcalcetide
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to ‘etelcalcetide gatekeeper’ approval only for secondary hyperparathyroidism – see NICE TA
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NICE TA448: Etelcalcetide for treating secondary hyperparathyroidism
Calcitriol injection
(Hyperparathyroidism)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved for percutaneous injection into the parathyroid gland for hyperparathyroidism if intolerant or unresponsive to oral therapy (November 2013)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.05.01.03  Magnesium to top
Magnesium Aspartate
(Magnaspartate®)
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Approved for magnesium deficiency (JFC March 2017)

Provider notes

  • NMUH:
    • See link below to access Trust Formulary bulletin on oral Magnesium Aspartate
  • RFL:
    • Non-formulary
  • RNOH:
    • For patients requiring enteral administration i.e. NG/PEG admin or with swallowing difficulties
  • UCLH:
    • Second line to NeoMag®
  • WH:
    • First line treatment for hypomagnesaemia (approved by NCL JCF Mar17). Magnesium glycerophosphate only for patients unable to tolerate magnesium aspartate.
 
Link  NMUH: Trust Formulary bulletin on oral Magnesium Aspartate
Magnesium glycerophosphate 4mmol/tablet
View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • The BNF states that to prevent recurrence of hypomagnesaemia in adults, oral magnesium may be given in a dose of 24 mmol Mg2+ daily in divided doses. In children aged 1 month to 12 years, the BNF for children recommends that the initial dose of oral magnesium for hypomagnesaemia is 0.2 mmol/kg Mg2+ three times daily, with the dose adjusted as needed. In children aged 12 to 18 years, it recommends that the initial dose is 4 to 8 mmol Mg2+ three times daily, adjusted as needed.
  • UCLH:
  • WH:
    • First line treatment for hypomagnesemia is magnesium aspartate. Magnesium glycerophosphate should only be used for patients unable to tolerate magnesium aspartate.
 
Magnesium Hydroxide Mixture BP
View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • BCF: No restriction (historical)
    • RFH: Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Magnesium sulfate injection
View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Only magnesium sulphate 50% injection stocked
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • The use of magnesium sulphate inj 10% & 20% are restricted to Obstetrics only.
 
Magnesium lactate modified-release
(MagTab®)
(Renal tubular disorders)
View childrens BNF
Unlicensed Drug Unlicensed
GP - Red
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Renal tubular disorders outpatients clinic only (RFL only; JFC September 2018)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.05.02  Phosphorus
09.05.02.01  Phosphate supplements
Phosphate Polyfusor®
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Phosphate supplements
(Phosphate-Sandoz®)
View adult BNF View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Sodium dihydrogen phosphate oral solution
View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
AAAAAAAA

Provider notes

  • NMUH:
    • For the treatment of hypophosphataemia or premature bone disease in paediatric patients. For further prescribing information, refer to the BNF for Children. 
  • RFL:
    • For neonates & paediatrics
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.05.02.02  Phosphate-binding agents
Calcium acetate + Magnesium carbonate tabs
(Osvaren®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to renal patients only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Calcium acetate tabs
(Phosex®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to renal patients only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Calcium carbonate
(Adcal®)
(Phosphate binder)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Calcium carbonate
(Calcichew®)
(Phosphate binder)
View adult BNF View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Calcichew is available on the Formulary for the management of hyperphosphotaemia in renal patients
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Lanthanum (Fosrenol ®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to renal patients only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Sevelamer carbonate
View adult BNF View SPC online View childrens BNF
Formulary
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Restricted to renal patients only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Sevelamer hydrochloride
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to renal patients only - not preferred – use sevelamer carbonate preferentially
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.05.03  Fluoride
Fluorides
(Duraphat® Toothpaste)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • 0.619% toothpaste available for Simmons House and Islington community clinics only 
 
Fluorides
(En-De-Kay® Oral Drops)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • For Islington community only
 
Fluorides
(En-De-Kay® Tablet)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • For Islington Community Only - direct ward delivery
 
09.05.04  Zinc to top
Zinc sulfate 125 mg effervescent tablets
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Only to be used where there is good evidence of deficiency. Therapy to be discontinued when clinical improvement occurs.
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Zinc sulfate 220 mg capsules
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.05.05  Selenium
09.06  Vitamins
09.06.01  Vitamin A
Vitamins A C and D
(Healthy start children’s vitamin drops)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • For community clinics only
 
09.06.02  Vitamin B group
Pabrinex®
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Pyridoxine Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Only the 50mg tablets kept at the RFH
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Thiamine tabs
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

 Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Thiamine Injection 100 mg in 1mL
View childrens BNF
Unlicensed Drug Unlicensed
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.06.02  Oral vitamin B complex preparations to top
Vitamin B Tablets, Compound
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Vitamin B Tablets, Compound Strong
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
09.06.02  Other compounds
09.06.03  Vitamin C
Ascorbic Acid (Vitamin C)
(Supplement)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Tablets 50mg,100mg, 200mg and 500mg
    • Injection 500mg
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
09.06.04  Vitamin D
Alfacalcidol
(One-Alpha®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • See link below
  • RFL:
    • No restriction stated
  • RNOH:
    • Store in refrigerator
  • UCLH:
  • WH:
    • No restriction stated
 
Calcitriol oral
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • See link below
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Calcium and Ergocalciferol
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
Colecalciferol + Calcium carbonate
(Adcal-D3®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • See links below
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NCL JFC: Guidelines for Calcium and Vitamin D supplementation for the prevention of osteoporotic fragility fractures
Colecalciferol caps/liquid
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • See links below
  • RFL:
    • No restriction stated
  • RNOH:
    • Oral liquid available as 3000 units/mL
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NCL JFC: Guidelines for Calcium and Vitamin D supplementation for the prevention of osteoporotic fragility fractures
Ergocalciferol
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • 300,000 units intramuscular injection only
  • RNOH:
    • Restricted
  • UCLH:
  • WH:
    • Inj 7.5 mg (300,000 units)/1 ml only
 
09.06.05  Vitamin E
Alpha Tocopheryl Acetate
(Vitamin E)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Oral suspension and injection 100mg/2ml kept at the RFH.
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.06.06  Vitamin K to top
Menadiol sodium diphosphate
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • 10 mg tablets stored in the EDC
  • UCLH:
  • WH:
    • No restriction stated
 
Phytomenadione 10 mg in 1 mL injection
(Konakion® MM)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Can be given undiluted by slow intravenous injection over at least 30 seconds - see Medusa Injectable Medicines Guide for further information
  • UCLH:
  • WH:
    • Konakion MM may be administered by slow intravenous injection, or by intravenous infusion in glucose 5%, at a rate of not less than 1 mg/minute. It is currently unlicensed for use by intramuscular injection, although it can be given by this route on the prescriber’s responsibility.
 
Phytomenadione 2 mg in 0.2 mL
(Konakion® MM Paediatric)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Konakion MM Paediatric can be administered by intramuscular or intravenous injection or by oral administration depending on the indication - see the SPC for further information
  • UCLH:
  • WH:
    • This is the only vitamin K preparation licensed for oral administration. As an alternative there is Phytomenadione 20 mg/ml oral drops (unlicensed).
 
Phytomenadione 20 mg in 1 mL oral drugs
View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Please note that this preparation is NOT LICENSED for use in the UK
 
09.06.07  Multivitamin preparations
Multivitamin
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Multivitamin liquid
(Abidec®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Discharge prescribing for neonates only
 
Multivitamin liquid
(Dalivit®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
09.06.07  Vitamin and mineral supplements and adjuncts to synthetic diets
Multivitamin (Renavit®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Approved for vitamin deficiency in chronic kidney disease (April 2015)

Provider notes

  • NMUH:
    • For continuation of treatment. Initiation by the renal team ONLY.
  • RFL:
    • Preferred multivitamin for CKD - renal team only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Vitamin and mineral supplements
(DEKAs® Plus)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Approved for the dietary management of patients with cystic fibrosis on the specific recommendation of a specialist in cystic fibrosis; available as capsules ("Softcaps"), chewable tablets ("Chewables") and liquid ("Liquid") (JFC September 2018).

Provider notes

  • NMUH:
    • For continuation only. Not stocked but ordered in if patient admitted on supplement as per indication stated above
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Initiation as above only
 
Vitamin and mineral supplements
(Forceval Soluble®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

GP-RedRed (hospital only prescribing) for refeeding syndrome

Grey for other indications

 

Approved for prophylaxis of refeeding syndrome (JFC October 2018)

Provider notes

  • NMUH:
    • For refeeding syndrome ONLY - refer to Trust Guideline
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Refeeding syndrome only
 
Vitamin and mineral supplements
(Forceval®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Vitamin and mineral supplements
(Ketovite®)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Not preferred – use Renavit preferentially for CKD - renal team only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.07  Bitters and tonics
09.08  Metabolic disorders
09.08.01  Drugs used in metabolic disorders to top
Eliglustat
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
High Cost Medicine
AAAAAAAA

See NICE HST for eligibility criteria

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Gaucher disease in line with NICE HST
  • RNOH:
    • Non-formulary
  • UCLH:
    • Gaucher disease in line with NICE HST
  • WH:
    • Non-formulary
 
Link  NICE HST5: Eliglustat for treating type 1 Gaucher disease
Idursulfase
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Ubiquinone
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
    • Primary mitochondrial deficiency in patients with confirmed mitochondrial defect or defined respiratory chain deficiency (August 2016)
  • WH:
    • Non-formulary
 
Biotin
View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to paediatrics and neonates
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
09.08.01  Wilsons disease
Penicillamine
(Metabolic disorders)
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Trientine Dihydrochloride
(Metabolic disorders)
View adult BNF View SPC online View childrens BNF
Formulary
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted for Wilson’s specialist use only
    • See NHSE clinical commissioning policy
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NHSE 170094P: Trientine for Wilson disease (all ages)
Zinc acetate (Wilzin®)
(Metabolic disorders)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.08.01  Carnitine deficiency
Levocarnitine
(l-carnitine)
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary for paediatrics (GOSH specialist service)
    • For peritoneal dialysis patients (levocarnitine deficiency)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.08.01  Fabry's disease
Agalsidase alfa and beta
(Fabrazyme®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Agalsidase alfa and beta
(Replagal®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Elosulfase alfa
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

See NICE HST for eligibility criteria

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Morquio A Syndrome in line with NICE HST
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NICE HST2: Elosulfase alfa for treating mucopolysaccharidosis type IVa (Morquio A Syndrome)
Migalastat caps
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

See NICE HST for eligibility criteria

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Fabry disease in line with NICE HST
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NICE HST4: Migalastat for treating Fabry disease
09.08.01  Gaucher's disease
Imiglucerase
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Miglustat
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Velaglucerase alfa
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.08.01  Mucopolysaccharidosis I to top
Galsulfase
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Laronidase
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.08.01  Pompe disease
Alglucosidase Alfa
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the lysosomal storage disorders unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.08.01  Nephropathic cystinosis
Mercaptamine
(Cystagon®, Procysbi®)
(Cystinosis)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to renal team
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.08.01  Urea cycle disorders
Arginine
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • For peritoneal dialysis patients only (arginine deficiency)
    • Non-formulary for other indications (inc. paediatrics)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Sodium benzoate
View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary (inc. paediatrics)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.08.02  Acute porphyrias
Haem Arginate
(Normosang®)
(human hemin)
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
09.08.02  Drugs unsafe for use in acute porphyrias to top
09.09  Unlicensed Medicines / Significant off-label use
Azathioprine
(Haematology)
View adult BNF View SPC online View childrens BNF
Formulary
High Cost Medicine
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
  • RFL:
    • Approved for Immune thrombocytopenia (ITP) and Autoimmune Haemolytic Anaemia (AIHA)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
 
Ciclosporin
(Haematology)
View adult BNF View SPC online View childrens BNF
Formulary
High Cost Medicine
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
  • RFL:
    • Approved for Immune thrombocytopenia (ITP) and Autoimmune Haemolytic Anaemia (AIHA)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
 
Cyclophosphamide tablets
(Haematology)
View adult BNF View SPC online View childrens BNF
Formulary
High Cost Medicine

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
  • RFL:
    • Approved for Immune thrombocytopenia (ITP) and Autoimmune Haemolytic Anaemia (AIHA)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
 
Danazol
(Haematology)
View adult BNF View SPC online View childrens BNF
Formulary
High Cost Medicine
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
  • RFL:
    • Approved for Immune thrombocytopenia (ITP) and Autoimmune Haemolytic Anaemia (AIHA)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
 
Eculizumab infusion
(Hyperhaemolysis)
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Approved for 2nd line management of Delayed Haemolytic Transfusion Reactions [DHTRs] hyperhaemolysis in adult Sickle Cell and β-thalassaemia patients who have not responded to IVIG and steroids (pending internal funding approval; JFC July 2019)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
    • Restricted to haematology. UMC to be informed of each patient. Funding agreed for 1 patient per annum. 
  • WH:
    • Non-formulary
 
Mycophenolate mofetil
(Haematology)
View adult BNF View SPC online View childrens BNF
Formulary
High Cost Medicine
AAAAAAAA

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
  • RFL:
    • Approved for Immune thrombocytopenia (ITP) and Autoimmune Haemolytic Anaemia (AIHA)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
 
 ....
 Non Formulary Items
Alpha Tocopherol
(Vedrop®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Asfotase alfa injection

View adult BNF View SPC online View childrens BNF
Non Formulary

See NICE HST for eligibility criteria

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE HST6: Asfotase alfa for treating paediatric-onset hypophosphatasia
Babiven start up

View adult BNF View SPC online View childrens BNF
Non Formulary
Betaine
(Homocystinuria)

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red
Calcium acetate tabs
(Renacet®)

View childrens BNF
Non Formulary
Calcium carbonate
(Calcium-500®)
(Calcium supplement)

View adult BNF View SPC online View childrens BNF
Non Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Calcium carbonate
(Calcium-500®)
(Phosphate binder)

View adult BNF View SPC online View childrens BNF
Non Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Calcium Lactate tablets

View adult BNF View SPC online View childrens BNF
Non Formulary
Carglumic acid

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red
High Cost Medicine
Cerliponase alfa

View adult BNF View SPC online View childrens BNF
Non Formulary

See NICE HST for eligibility criteria

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE HST12: Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2
Chenodexoycholic acid
(Xenbilox®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Citrulline

View adult BNF View SPC online View childrens BNF
Non Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
    • Approved for adult Inherited Metabolic Disorders (UCLH only; JFC October 2020).
  • WH:
    • Non-formulary
Colecalciferol + Calcium carbonate
(Accrete D3®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol + Calcium carbonate
(Cacit® D3)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol + Calcium carbonate
(Calceos®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol + Calcium carbonate
(Calchichew-D3 Once Daily)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol + Calcium carbonate
(Calcichew-D3®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol + Calcium carbonate
(Calcichew-D3® Forte)

View adult BNF View SPC online View childrens BNF
Non Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Colecalciferol + Calcium carbonate
(Calci-D®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol + Calcium carbonate
(Kalcipos-D®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol + Calcium carbonate
(Natecal D3®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol + Calcium carbonate
(TheiCal- D3)

View adult BNF View SPC online View childrens BNF
Non Formulary
Colecalciferol with Calcium phosphate
(Calfovit D3®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Creatine

View adult BNF View SPC online View childrens BNF
Non Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
    • Approved for adult Inherited Metabolic Disorders (UCLH only; JFC October 2020).
  • WH:
    • Non-formulary
Dextran 40 ®

View adult BNF View SPC online View childrens BNF
Non Formulary
Dextran 70 + Sodium chloride hypertonic intravenous

View adult BNF View SPC online View childrens BNF
Non Formulary
Dextran 70 intravenous

View adult BNF View SPC online View childrens BNF
Non Formulary
Dihydrotachysterol
(AT 10®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Eculizumab infusion
(Paroxysmal nocturnal haemoglobinuria)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Not approved for the treatment of paroxysmal nocturnal haemoglobinuria (PNH); see UCLH DTC minutes October 2007.

Efmoroctocog alfa
(Elocta®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Epoetin alfa (Binocrit®)

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red

Approved to treat anaemia (and prevent ribavirin dose reduction) in patients treated for hepatitis C virus (October 2013)

Epoetin theta
(Eporatio®)

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red
Link  NICE TA323: Erythropoiesis‑stimulating agents during chemotherapy
Epoetin zeta (Retacrit®)

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red
Link  NICE TA323: Erythropoiesis‑stimulating agents during chemotherapy
Etherified Starch
(HAES-steril®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Etherified Starch
(Hemohes®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Etherified Starch
(Infukoll®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Ferric maltol caps

View adult BNF View SPC online View childrens BNF
Non Formulary
Ferrous fumarate + Folic acid
(Galfer FA®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Ferrous sulfate + Folic acid
(Fefol®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Ferrous sulphate + Folic acid
(Ferrograd Folic®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Ferrous sulphate modified release
(Feospan®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Ferrous sulphate oral drops
(Ironorm® drops)

View adult BNF View SPC online View childrens BNF
Non Formulary
Fluorides
(Duraphat® Mouthwash)

View adult BNF View SPC online View childrens BNF
Non Formulary
Fluorides
(En-De-Kay® Mouthwash)

View adult BNF View SPC online View childrens BNF
Non Formulary
Fluorides
(Flour-a-day® Tablet)

View adult BNF View SPC online View childrens BNF
Non Formulary
Fluorides
(FlouriGard® Gel)

View adult BNF View SPC online View childrens BNF
Non Formulary
Fluorides
(FlouriGard® Mouthwash)

View adult BNF View SPC online View childrens BNF
Non Formulary
Fluorides
(FluoriGard® Tablet)

View adult BNF View SPC online View childrens BNF
Non Formulary
Gelatin intravenous infusion
(Haemaccel®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Glycerol phenylbutyrate

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
    • Approved for urea cycle disorders for patients who cannot be managed by dietary protein restriction and/or amino acid supplementation alone (UCLH only; JFC October 2018)
  • WH:
    • Non-formulary
Hypertonic Solution
(HyperHAES®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Intralipid 20%

View adult BNF View SPC online View childrens BNF
Non Formulary
Iron Isomaltoside
(Diafer®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Lipegfilgrastim
(Patients with a history of severe neutropenia despite prophylactic daily GCSF)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Not approved for patients with a history of severe neutropenia despite prophylactic daily GCSF (August 2016)

Magnesium oxide tabs/caps

View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
Mercaptamine eye drops
(Cystadrops®)
(Cystinosis)

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red
High Cost Medicine
Methionine

View adult BNF View SPC online View childrens BNF
Non Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
    • Approved for adult Inherited Metabolic Disorders (UCLH only; JFC October 2020).
  • WH:
    • Non-formulary
Molgramostim

View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
GP - Red
Multivitamin eye supplement
(MaculEH Light®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Multivitamin including lutein
(PreserVision®, Vitalux Plus®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Multivitamin including lutein
(Vitalux Plus®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Multivitamin including lutein and zeaxanthin
(ICaps®, Macushield®, Ocuvite®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Multivitamin including lutein and zeaxanthin
(Macushield®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Multivitamin including lutein and zeaxanthin
(Ocuvite®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Nitisinone

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red
Nutryelt ®

View adult BNF View SPC online View childrens BNF
Non Formulary
Oral Rehydration Salts
(Electrolade®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Oral Rehydration Salts
(Rapolyte®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Other Compounds
(Potaba®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Oxymetholone

View adult BNF View SPC online View childrens BNF
Non Formulary
Paricalcitol

View adult BNF View SPC online View childrens BNF
Non Formulary
Pegfilgrastim
(Patients with a history of severe neutropenia despite prophylactic daily GCSF)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black
High Cost Medicine

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Not approved for patients with a history of severe neutropenia despite prophylactic daily GCSF (August 2016)

Pegfilgrastim
(Patients who cannot inject daily)

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Phytomenadione capsules

View adult BNF View SPC online View childrens BNF
Non Formulary
Plasma-lyte 148 with Glucose 5%

View adult BNF View SPC online View childrens BNF
Non Formulary
Plerixafor

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Polysaccharide Iron Complex
(Miferex®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Potasium Chloride
(Klofer®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Potassium Bicarbonate
(Effervescent tablets)

View adult BNF View SPC online View childrens BNF
Non Formulary
Potassium Chloride 20mmol in 20ml Water For Injection

View adult BNF View childrens BNF
Non Formulary
Potassium Chloride 40mmol in 50ml Water For Injection

View adult BNF View childrens BNF
Non Formulary
Potassium Chloride 50mmol in 50mL Sodium Chloride 0.9% prefilled syringe

View adult BNF View childrens BNF
Non Formulary
Potassium dihydrogen phosphate
(Potassium acid phosphate)

View childrens BNF
Non Formulary
Preparations
(Forceval Protein Powder®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Riboflavin (Vitamin B2)

View adult BNF View SPC online View childrens BNF
Non Formulary
Sapropterin dihydrochloride

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red
High Cost Medicine
Sebelipase alfa

View adult BNF View SPC online View childrens BNF
Non Formulary
Selenium (Selenase®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Sodium Dichloroacetate

View childrens BNF
Non Formulary
Sodium phenylbutyrate
(Ammonaps®, Pheburane®)

View childrens BNF
Non Formulary
GP - Red
Sucroferric oxyhydroxide
(Velphoro®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Supplementary Preparations
(Decan®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Supplementary Preparations
(Dipeptiven®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Supplementary Preparations
(Glycophos® Sterile Concentrate)

View adult BNF View SPC online View childrens BNF
Non Formulary
Supplementary Preparations
(Tracutil®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Tetrastarch intravenous infusion
(Tetraspan®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Tetrastarch intravenous infusion
(Venofundin®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Tetrastarch intravenous infusion
(Volulyte®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Tetrastarch intravenous infusion
(Voluven®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Vitamin B complex preparations
(Vigranon B®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Vitamins C, D and folic acid
(Healthy start vitamins for women)

View adult BNF View SPC online View childrens BNF
Non Formulary
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Homecare
Homecare

Traffic Light Status Information

Status Description

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.  

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf

  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary